Kiera Kingston, MD
Orthopaedic Surgery · Chicago, ILNPI 1609303254
Payments from drug & device makers
What this record shows
The money is spread across several categories — grants (56.4%), education and travel and lodging — rather than concentrated in one kind of arrangement. Arthrex accounts for 63.4% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2022 at $24,558 and has fallen 88.3% since, to $2,877 in 2025.
Across 88 payments — averaging $547.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$31K
- Smith+Nephew$14K
- Lightbody Medical Technologies Inc$2K
- Stryker$893
- Suvon Surgical LLC$418
- Paragon 28, Inc.$119
- plus $363 from 7 others
What the payments were for
- Grants$27,14356%
- Travel & lodging$3,8218%
- Food & beverage$3,1727%
- Education$14,00029%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 45 | $30,514 |
| Smith+Nephew | 4 | $14,158 |
| Lightbody Medical Technologies Inc | 8 | $1,670 |
| Stryker | 14 | $893 |
| Suvon Surgical LLC | 5 | $418 |
| Paragon 28, Inc. | 3 | $119 |
| Orthopediatrics Corp. | 1 | $102 |
| Oak Med, Inc. | 1 | $78 |
| Kairos Surgical Inc | 3 | $52 |
| Solventum Corporation | 1 | $45 |
| Treace Medical Concepts, Inc. | 1 | $30 |
| Heron Therapeutics, Inc. | 1 | $28 |
| Vertex | 1 | $28 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$48,136 in reported general payments places this provider in the 85th percentile of 844 orthopaedic surgery providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 18 | $53 |
| Ondansetron Hcl | 17 | $40 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Chicago
- Aaron RosenbergChicago$12.4M
- Anish KadakiaChicago$2.1M
- Wellington HsuChicago$1.7M
- Ken YamaguchiChicago$1.7M
- Guido MarraChicago$1.2M
- Hue LuuChicago$1.1M
- Alpesh PatelChicago$917K
- Samuel StulbergChicago$852K
- Richard BergerChicago$618K
- Ari KazChicago$343K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.